FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> Vaccine | pneumonia
Syndicate content

Researchers: Pneumonia vax cuts heart disease risk

Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!



Tools
  • Subscribe
  • Email
  • Print
  • Contact Author
  • Reprint

A new study indicates that a pneumonia vaccine can significantly cut the risk of heart disease. The study, published in the Canadian Medical Association Journal, concluded that the vaccine reduced the risk of heart attacks in the elderly by as much as 50 percent.

"The magnitude of the effect was really surprising for us," said Dr. Danielle Pilon, the study's lead author and an associate professor of medicine at the Universite de Sherbrooke in Quebec. "We didn't expect the vaccine to lower the risk of heart attacks by such a high rate."

Researchers believe that the vaccine has anti-inflammatory properties, which inhibits the buildup of plaque in blood vessels. And they're urging physicians to use the pneumonia vaccine more liberally as a protection against heart attacks.

- read the report from Canada.com

Related Article:
Key target found for new pneumonia vaccine


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceVaccines Email Newsletter:

More stories about Vaccine   pneumonia